Safety and Tolerability Trial of Switching From Ropinirole to Rotigotine
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
This is a Phase 3b, open-label, multicenter trial to assess the safety and tolerability of
switching from ropinirole therapy to the rotigotine transdermal system and its effect on
symptoms in subjects with idiopathic Parkinson's disease